Martingale Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-34,797	Closed	-$122K	–	791
2024 Q3	$122K	Hold	34,797	–	–	﹤0.01%	779
2024 Q2	$114K	Buy	34,797 +887	+3%	+$2.91K	﹤0.01%	777
2024 Q1	$249K	Buy	+33,910	New	+$249K	0.01%	737